NorthWest Biotherapeutics Inc (NWBO)

[alphapuppy]

Meir. I totally agree, I think the data from JAMA should and I underline should be enough for approval.

However, we’re dealing with politics and money and regulatory agencies so you never know, I just remember what happened to DNDN and they had to do an entirely new trial.

Hope not, but if the combo is as good as has been presented, that will be additional data, unheard of survival data for this disease, which will help.

I’m just looking how those Harvard guys put an editorial in the SNO with Inaccuracy and got away with it

And I realize how intense people will fight against this.